pre-open, page-7

Part of today's ASX release:

"Peptech Limited today announced it has completed a share plaosment raising approximately $10 million from leading Australian Institutions including AMP, INIE Australia and the Escor Group. Peptech will issue 6,625,000 shares at $1.55 to raise $10.3 million before costs associated with the issue.

Peptech Managing Director Stephen Kwik, said "the funds will be used in part to fund further development of single domain antibodies against TNF currently being developed by Domantis and to provide additional working capital. The capital raising places Peptech in a strong cash position."